Consonance Capital Management LP

Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol: KROS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2021		-4.5%	$0	0	-887,885	-100%	$17.24	Q3 2021
30 Jun 2021	4.5%	-0.01%	$37,708,000	887,885	-2,324	-0.26%	$42.47	Q2 2021
31 Mar 2021	5.8%	+2.2%	$54,792,000	890,209	+333,114	+60%	$61.55	Q1 2021
31 Dec 2020	3.9%	+3.9%	$39,297,000	557,095	+557,095	NEW	$70.54	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.